IVAX Diagnostics, Inc. (IVAX Diagnostics) through its subsidiaries, is engaged in developing, manufacturing, and marketing diagnostic test kits, reagents, and instruments for use in hospitals, reference laboratories, clinical laboratories, research laboratories, doctors’ offices, and other commercial companies. The Company’s products and instrumentation are sold primarily to customers in the United States and Italy. IVAX Diagnostics is the parent corporation of three subsidiaries: Delta Biologicals, S.r.l., Diamedix Corporation, and ImmunoVision, Inc. Its products are primarily associated with the in vitro diagnostics market. Most of the Company's tests are based on Enzyme Linked ImmunoSorbent Assay (ELISA) technology.